BOSTON, May 5, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company"), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced that its Board of Directors has approved an effective time at...
Read More Details
Finally We wish PressBee provided you with enough information of ( TransCode Therapeutics Announces Effective Date for 1-for-28 Reverse Stock Split )
Also on site :
- Anne Burrell's Husband Looks Somber in First Photo Since Food Network Star's Death
- Iran threatens US bases in Middle East, asserts nuclear facilities undamaged
- Start your week smart: US strikes Iran, Pride rollbacks, Tesla robotaxis, NATO summit, Bezos’ wedding